Microbiome Disease Clinical Trial Analysis: Key Insights Into Rich Pipeline Featuring 140+ Companies And 180+ Therapies | Delveinsight
The potential of the microbiome in disease treatment and prevention is an emerging and highly promising field in medicine. Research into microbiome-b ...
Medscape27d
Topical Antibiotic Treatment for Uncomplicated Skin and Skin Structure Infections: Review of the Literature
Currently, there are promising new topical antibiotics, including mupirocin and retapamulin, seeking indication for bacterial skin infections. These topical antibiotics may have a role in the ...
pharmaphorum29d
Shire’s new chairman will be second only woman to lead a FTSE 100
Shire also announced, on January 24th, that it had completed the merger of ViroPharma with one of its subsidiaries. Shire taps ex-investment banker Susan Kilsby to chair its board (FiercePharma).
BioWorld1mon
ViroPharma, Washington U., Find Drug To Treat Pestivirus Livestock Plagues - With Hepatitis C Kicker
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on ...
JD Supra1y
FTC v Actavis
On May 13—and more than ten years after Federal Trade Commission v. Actavis, the leading U.S. Supreme Court case on reverse payment settlements—the Second Circuit for the first time weighed in ...